During perimenopause, they can be even more frustrating when you have no clue what to expect from one month to the next
Therefore, in the interpretation of semaglutide-related oral adverse effects we integrated indirect evidencefrom transcriptomic datasets, pancreatic and GPCR signaling models, -arrestin biology, and pharmacokinetic behavior
Contraindications and precautions include: Personal or family history of medullary thyroid carcinoma (contraindicated) Multiple endocrine neoplasia syndrome type 2 (MEN 2) (contraindicated) Pregnancy or planning pregnancy (not recommended) Breastfeeding (not recommended) History of severe hypersensitivity to tirzepatide or excipients History of pancreatitis (requires careful assessment) Gallbladder disease or risk factors Severe gastrointestinal disease Diabetic retinopathy (requires monitoring if present) Suicidal thoughts or behaviors (monitor for depression/suicidal ideation) Patients should be advised about reduced oral contraceptive effectiveness and the need for alternative or backup contraception for 4 weeks after initiation and each dose increase
Nausea peaks during the first few days after each dose bump
GLP-1RAs as a support for MCAS For some basics: glucagon-like peptide-1 receptor agonists (abbreviated as GLP-1 medications or as I noted above, GLP-1RAs) are a class of medications that includes semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound, which also work on GIP receptors), as well as in-trials Retatrutide (a triple agonist that works on GLP-1, GIP, and Glucagon receptors)
Semaglutide helped me find balance. Addressing Common Concerns Many potential users may have questions about side effects or how long it takes to see results with semaglutide
